Loading…
Reported covered position: Counsel, House Judiciary Committee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Veterans Infertility Treatment Act of 2021
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S.2352, the Access to Infertility Treatment and Care Act Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem.... S.Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) H.R. 1957, Veterans Infertility Treatment Act Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare H.Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States
Veterans Infertility Treatment Act of 2021
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2022 · third_quarter · Q3
Issues related to advancing H.R. 4450 and S. 2352, the Access to Infertility Treatment and Care Act; Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem; S.Res. 325, A Resolution Recognizing the Seriousness of Polycystic Ovary Syndrome (PCOS); H.R. 1957 Veterans Infertility Treatment Act; H.Res. 539, A Resolution Recognizing the Maternal Health Crisis in the United States; Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA), White House Office
Source: Senate LDA
Issues related to advancing H.R. 4450 and S. 2352, the Access to Infertility Treatment and Care Act; Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem; S.Res. 325, A Resolution Recognizing the Seriousness of Polycystic Ovary Syndrome (PCOS); H.R. 1957 Veterans Infertility Treatment Act; H.Res. 539, A Resolution Recognizing the Maternal Health Crisis in the United States; Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare.
Veterans Infertility Treatment Act of 2021
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S.2352, the Access to Infertility Treatment and Care Act Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem.... S.Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) H.R. 1957, Veterans Infertility Treatment Act Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare H.Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S.2352, the Access to Infertility Treatment and Care Act Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem.... S.Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) H.R. 1957, Veterans Infertility Treatment Act Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare H.Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S.2352, the Access to Infertility Treatment and Care Act Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem.... S.Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) H.R. 1957, Veterans Infertility Treatment Act Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare H.Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S. 2352, the Access to Infertility Treatment and Care Act; Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem; S.Res. 325, A Resolution Recognizing the Seriousness of Polycystic Ovary Syndrome (PCOS); H.R. 1957 Veterans Infertility Treatment Act; H.Res. 539, A Resolution Recognizing the Maternal Health Crisis in the United States; Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare.
Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders.
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S.2352, the Access to Infertility Treatment and Care Act Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem.... S.Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) H.R. 1957, Veterans Infertility Treatment Act Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare H.Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States
Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders.
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S.2352, the Access to Infertility Treatment and Care Act Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem.... S.Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) H.R. 1957, Veterans Infertility Treatment Act Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare H.Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States
Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders.
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S. 2352, the Access to Infertility Treatment and Care Act; Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem; S.Res. 325, A Resolution Recognizing the Seriousness of Polycystic Ovary Syndrome (PCOS); H.R. 1957 Veterans Infertility Treatment Act; H.Res. 539, A Resolution Recognizing the Maternal Health Crisis in the United States; Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare.
Recognizing the maternal health crisis in the United States and the importance of reducing mortality and morbidity among all women, and honoring mothers.
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S.2352, the Access to Infertility Treatment and Care Act Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem.... S.Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) H.R. 1957, Veterans Infertility Treatment Act Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare H.Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States
Recognizing the maternal health crisis in the United States and the importance of reducing mortality and morbidity among all women, and honoring mothers.
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S.2352, the Access to Infertility Treatment and Care Act Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem.... S.Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) H.R. 1957, Veterans Infertility Treatment Act Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare H.Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States
Recognizing the maternal health crisis in the United States and the importance of reducing mortality and morbidity among all women, and honoring mothers.
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S. 2352, the Access to Infertility Treatment and Care Act; Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem; S.Res. 325, A Resolution Recognizing the Seriousness of Polycystic Ovary Syndrome (PCOS); H.R. 1957 Veterans Infertility Treatment Act; H.Res. 539, A Resolution Recognizing the Maternal Health Crisis in the United States; Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare.
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S.2352, the Access to Infertility Treatment and Care Act Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem.... S.Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) H.R. 1957, Veterans Infertility Treatment Act Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare H.Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S. 2352, the Access to Infertility Treatment and Care Act; Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem; S.Res. 325, A Resolution Recognizing the Seriousness of Polycystic Ovary Syndrome (PCOS); H.R. 1957 Veterans Infertility Treatment Act; H.Res. 539, A Resolution Recognizing the Maternal Health Crisis in the United States; Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare.
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S.2352, the Access to Infertility Treatment and Care Act Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem.... S.Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) H.R. 1957, Veterans Infertility Treatment Act Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare H.Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States
A resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of September 2021 as "PCOS Awareness Month".
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S. 2352, the Access to Infertility Treatment and Care Act; Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem; S.Res. 325, A Resolution Recognizing the Seriousness of Polycystic Ovary Syndrome (PCOS); H.R. 1957 Veterans Infertility Treatment Act; H.Res. 539, A Resolution Recognizing the Maternal Health Crisis in the United States; Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare.
A resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of September 2021 as "PCOS Awareness Month".
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S.2352, the Access to Infertility Treatment and Care Act Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem.... S.Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) H.R. 1957, Veterans Infertility Treatment Act Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare H.Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States
A resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of September 2021 as "PCOS Awareness Month".
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to advancing H.R. 4450 and S.2352, the Access to Infertility Treatment and Care Act Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem.... S.Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) H.R. 1957, Veterans Infertility Treatment Act Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare H.Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill) H.R. 1957 - Veterans Infertility Treatment Act of 2021
Veterans Infertility Treatment Act of 2021
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 4450 / S. 2352 - Access to Infertility Treatment and Care Act (Entire bill); H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders (Entire resolution); H.R. 1957 - Veterans Infertility Treatment Act of 2021 (Entire bill); H.R. 2734 / S.1280 - Veteran Families Health Services Act of 2021 (Entire bill); H.R. 6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act (Entire bill); H.R. 7900 - National Defense Authorization Act (NDAA) for Fiscal Year 2023 (Issues related to fertility coverage for members of the military); H.R. 8237 - Legislative Branch Appropriations Act, 2023 (Issues related to fertility coverage); H.R. 8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023 (Issues related to fertility coverage for members of the military); H.R. 4432 - Department of Defense Appropriations Act, 2022 (Issues related to fertility coverage for members of the military); S. Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (Entire bill); H. Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States (Entire resolution)
Veterans Infertility Treatment Act of 2021
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill) H.R. 1957 - Veterans Infertility Treatment Act of 2021
Veterans Infertility Treatment Act of 2021
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 1957 - Veterans Infertility Treatment Act and issues related to mandating health coverage for military veterans
Veteran Families Health Services Act of 2021
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 4450 / S. 2352 - Access to Infertility Treatment and Care Act (Entire bill); H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders (Entire resolution); H.R. 1957 - Veterans Infertility Treatment Act of 2021 (Entire bill); H.R. 2734 / S.1280 - Veteran Families Health Services Act of 2021 (Entire bill); H.R. 6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act (Entire bill); H.R. 7900 - National Defense Authorization Act (NDAA) for Fiscal Year 2023 (Issues related to fertility coverage for members of the military); H.R. 8237 - Legislative Branch Appropriations Act, 2023 (Issues related to fertility coverage); H.R. 8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023 (Issues related to fertility coverage for members of the military); H.R. 4432 - Department of Defense Appropriations Act, 2022 (Issues related to fertility coverage for members of the military); S. Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (Entire bill); H. Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States (Entire resolution)
Agriculture Resilience Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill) H.R. 1957 - Veterans Infertility Treatment Act of 2021
Elijah E. Cummings Lower Drug Costs Now Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Elijah E. Cummings Lower Drug Costs Now Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Elijah E. Cummings Lower Drug Costs Now Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Elijah E. Cummings Lower Drug Costs Now Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill) H.R. 1957 - Veterans Infertility Treatment Act of 2021
Department of Defense Appropriations Act, 2022
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 4450 / S. 2352 - Access to Infertility Treatment and Care Act (Entire bill); H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders (Entire resolution); H.R. 1957 - Veterans Infertility Treatment Act of 2021 (Entire bill); H.R. 2734 / S.1280 - Veteran Families Health Services Act of 2021 (Entire bill); H.R. 6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act (Entire bill); H.R. 7900 - National Defense Authorization Act (NDAA) for Fiscal Year 2023 (Issues related to fertility coverage for members of the military); H.R. 8237 - Legislative Branch Appropriations Act, 2023 (Issues related to fertility coverage); H.R. 8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023 (Issues related to fertility coverage for members of the military); H.R. 4432 - Department of Defense Appropriations Act, 2022 (Issues related to fertility coverage for members of the military); S. Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (Entire bill); H. Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States (Entire resolution)
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 4450 / S. 2352 - Access to Infertility Treatment and Care Act (Entire bill); H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders (Entire resolution); H.R. 1957 - Veterans Infertility Treatment Act of 2021 (Entire bill); H.R. 2734 / S.1280 - Veteran Families Health Services Act of 2021 (Entire bill); H.R. 6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act (Entire bill); H.R. 7900 - National Defense Authorization Act (NDAA) for Fiscal Year 2023 (Issues related to fertility coverage for members of the military); H.R. 8237 - Legislative Branch Appropriations Act, 2023 (Issues related to fertility coverage); H.R. 8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023 (Issues related to fertility coverage for members of the military); H.R. 4432 - Department of Defense Appropriations Act, 2022 (Issues related to fertility coverage for members of the military); S. Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (Entire bill); H. Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States (Entire resolution)
Expanding Access to Fertility Care for Servicemembers and Dependents Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 4450 / S. 2352 - Access to Infertility Treatment and Care Act (Entire bill); H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders (Entire resolution); H.R. 1957 - Veterans Infertility Treatment Act of 2021 (Entire bill); H.R. 2734 / S.1280 - Veteran Families Health Services Act of 2021 (Entire bill); H.R. 6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act (Entire bill); H.R. 7900 - National Defense Authorization Act (NDAA) for Fiscal Year 2023 (Issues related to fertility coverage for members of the military); H.R. 8237 - Legislative Branch Appropriations Act, 2023 (Issues related to fertility coverage); H.R. 8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023 (Issues related to fertility coverage for members of the military); H.R. 4432 - Department of Defense Appropriations Act, 2022 (Issues related to fertility coverage for members of the military); S. Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (Entire bill); H. Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States (Entire resolution)
National Defense Authorization Act for Fiscal Year 2023
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 4450 / S. 2352 - Access to Infertility Treatment and Care Act (Entire bill); H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders (Entire resolution); H.R. 1957 - Veterans Infertility Treatment Act of 2021 (Entire bill); H.R. 2734 / S.1280 - Veteran Families Health Services Act of 2021 (Entire bill); H.R. 6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act (Entire bill); H.R. 7900 - National Defense Authorization Act (NDAA) for Fiscal Year 2023 (Issues related to fertility coverage for members of the military); H.R. 8237 - Legislative Branch Appropriations Act, 2023 (Issues related to fertility coverage); H.R. 8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023 (Issues related to fertility coverage for members of the military); H.R. 4432 - Department of Defense Appropriations Act, 2022 (Issues related to fertility coverage for members of the military); S. Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (Entire bill); H. Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States (Entire resolution)
Legislative Branch Appropriations Act, 2023
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 4450 / S. 2352 - Access to Infertility Treatment and Care Act (Entire bill); H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders (Entire resolution); H.R. 1957 - Veterans Infertility Treatment Act of 2021 (Entire bill); H.R. 2734 / S.1280 - Veteran Families Health Services Act of 2021 (Entire bill); H.R. 6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act (Entire bill); H.R. 7900 - National Defense Authorization Act (NDAA) for Fiscal Year 2023 (Issues related to fertility coverage for members of the military); H.R. 8237 - Legislative Branch Appropriations Act, 2023 (Issues related to fertility coverage); H.R. 8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023 (Issues related to fertility coverage for members of the military); H.R. 4432 - Department of Defense Appropriations Act, 2022 (Issues related to fertility coverage for members of the military); S. Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (Entire bill); H. Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States (Entire resolution)
Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 4450 / S. 2352 - Access to Infertility Treatment and Care Act (Entire bill); H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders (Entire resolution); H.R. 1957 - Veterans Infertility Treatment Act of 2021 (Entire bill); H.R. 2734 / S.1280 - Veteran Families Health Services Act of 2021 (Entire bill); H.R. 6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act (Entire bill); H.R. 7900 - National Defense Authorization Act (NDAA) for Fiscal Year 2023 (Issues related to fertility coverage for members of the military); H.R. 8237 - Legislative Branch Appropriations Act, 2023 (Issues related to fertility coverage); H.R. 8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023 (Issues related to fertility coverage for members of the military); H.R. 4432 - Department of Defense Appropriations Act, 2022 (Issues related to fertility coverage for members of the military); S. Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (Entire bill); H. Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States (Entire resolution)
Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders.
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 4450 / S. 2352 - Access to Infertility Treatment and Care Act (Entire bill); H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders (Entire resolution); H.R. 1957 - Veterans Infertility Treatment Act of 2021 (Entire bill); H.R. 2734 / S.1280 - Veteran Families Health Services Act of 2021 (Entire bill); H.R. 6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act (Entire bill); H.R. 7900 - National Defense Authorization Act (NDAA) for Fiscal Year 2023 (Issues related to fertility coverage for members of the military); H.R. 8237 - Legislative Branch Appropriations Act, 2023 (Issues related to fertility coverage); H.R. 8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023 (Issues related to fertility coverage for members of the military); H.R. 4432 - Department of Defense Appropriations Act, 2022 (Issues related to fertility coverage for members of the military); S. Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (Entire bill); H. Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States (Entire resolution)
Recognizing the maternal health crisis in the United States and the importance of reducing mortality and morbidity among all women, and honoring mothers.
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 4450 / S. 2352 - Access to Infertility Treatment and Care Act (Entire bill); H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders (Entire resolution); H.R. 1957 - Veterans Infertility Treatment Act of 2021 (Entire bill); H.R. 2734 / S.1280 - Veteran Families Health Services Act of 2021 (Entire bill); H.R. 6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act (Entire bill); H.R. 7900 - National Defense Authorization Act (NDAA) for Fiscal Year 2023 (Issues related to fertility coverage for members of the military); H.R. 8237 - Legislative Branch Appropriations Act, 2023 (Issues related to fertility coverage); H.R. 8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023 (Issues related to fertility coverage for members of the military); H.R. 4432 - Department of Defense Appropriations Act, 2022 (Issues related to fertility coverage for members of the military); S. Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (Entire bill); H. Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States (Entire resolution)
Veteran Families Health Services Act of 2021
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 4450 / S. 2352 - Access to Infertility Treatment and Care Act (Entire bill); H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders (Entire resolution); H.R. 1957 - Veterans Infertility Treatment Act of 2021 (Entire bill); H.R. 2734 / S.1280 - Veteran Families Health Services Act of 2021 (Entire bill); H.R. 6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act (Entire bill); H.R. 7900 - National Defense Authorization Act (NDAA) for Fiscal Year 2023 (Issues related to fertility coverage for members of the military); H.R. 8237 - Legislative Branch Appropriations Act, 2023 (Issues related to fertility coverage); H.R. 8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023 (Issues related to fertility coverage for members of the military); H.R. 4432 - Department of Defense Appropriations Act, 2022 (Issues related to fertility coverage for members of the military); S. Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (Entire bill); H. Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States (Entire resolution)
Transit to Trails Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill) H.R. 1957 - Veterans Infertility Treatment Act of 2021
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 4450 / S. 2352 - Access to Infertility Treatment and Care Act (Entire bill); H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders (Entire resolution); H.R. 1957 - Veterans Infertility Treatment Act of 2021 (Entire bill); H.R. 2734 / S.1280 - Veteran Families Health Services Act of 2021 (Entire bill); H.R. 6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act (Entire bill); H.R. 7900 - National Defense Authorization Act (NDAA) for Fiscal Year 2023 (Issues related to fertility coverage for members of the military); H.R. 8237 - Legislative Branch Appropriations Act, 2023 (Issues related to fertility coverage); H.R. 8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023 (Issues related to fertility coverage for members of the military); H.R. 4432 - Department of Defense Appropriations Act, 2022 (Issues related to fertility coverage for members of the military); S. Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (Entire bill); H. Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States (Entire resolution)
A resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of September 2021 as "PCOS Awareness Month".
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 4450 / S. 2352 - Access to Infertility Treatment and Care Act (Entire bill); H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders (Entire resolution); H.R. 1957 - Veterans Infertility Treatment Act of 2021 (Entire bill); H.R. 2734 / S.1280 - Veteran Families Health Services Act of 2021 (Entire bill); H.R. 6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act (Entire bill); H.R. 7900 - National Defense Authorization Act (NDAA) for Fiscal Year 2023 (Issues related to fertility coverage for members of the military); H.R. 8237 - Legislative Branch Appropriations Act, 2023 (Issues related to fertility coverage); H.R. 8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023 (Issues related to fertility coverage for members of the military); H.R. 4432 - Department of Defense Appropriations Act, 2022 (Issues related to fertility coverage for members of the military); S. Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (Entire bill); H. Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States (Entire resolution)
Consolidated Appropriations Act, 2021
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Consolidated Appropriations Act, 2021
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Consolidated Appropriations Act, 2021
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Prescription Drug STAR Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Prescription Drug STAR Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Prescription Drug STAR Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Prescription Drug STAR Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill) H.R. 1957 - Veterans Infertility Treatment Act of 2021
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Strengthening Average Sales Price Reporting Act of 2019
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Strengthening Average Sales Price Reporting Act of 2019
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Strengthening Average Sales Price Reporting Act of 2019
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill) H.R. 1957 - Veterans Infertility Treatment Act of 2021
Strengthening Average Sales Price Reporting Act of 2019
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Prescription Drug Pricing Reduction Act of 2019
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill) H.R. 1957 - Veterans Infertility Treatment Act of 2021
Prescription Drug Pricing Reduction Act of 2019
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Prescription Drug Pricing Reduction Act of 2019
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Prescription Drug Pricing Reduction Act of 2019
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Consolidated Appropriations Act, 2021
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales prices to Medicare, including relevant provisions in the Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Reproductive Health legislation including Access to Infertility Treatment and Care Act (S. 1461, H.R. 2803)
Legacies of War Recognition and Unexploded Ordnance Removal Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
S. 2960, H. 5965, "Access to Infertility Treatment Act." Legislation to require that health plans offered on the group and individual markets, in addition to the FEHB Program, TRICARE, and the VA provide coverage for in vitro fertility (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. H.R. 2097, "The Drug Pricing Transparency Act." Pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Legacies of War Recognition and Unexploded Ordnance Removal Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
S. 2960, H. 5965, "Access to Infertility Treatment Act." Legislation to require that health plans offered on the group and individual markets, in addition to the FEHB Program, TRICARE, and the VA provide coverage for in vitro fertility (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. H.R. 2097, "The Drug Pricing Transparency Act." Pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Prescription Drug STAR Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales prices to Medicare, including relevant provisions in the Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Reproductive Health legislation including Access to Infertility Treatment and Care Act (S. 1461, H.R. 2803)
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales prices to Medicare, including relevant provisions in the Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Reproductive Health legislation including Access to Infertility Treatment and Care Act (S. 1461, H.R. 2803)
Elijah E. Cummings Lower Drug Costs Now Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales prices to Medicare, including relevant provisions in the Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Reproductive Health legislation including Access to Infertility Treatment and Care Act (S. 1461, H.R. 2803)
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales prices to Medicare, including relevant provisions in the Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Reproductive Health legislation including Access to Infertility Treatment and Care Act (S. 1461, H.R. 2803)
Strengthening Average Sales Price Reporting Act of 2019
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales prices to Medicare, including relevant provisions in the Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Reproductive Health legislation including Access to Infertility Treatment and Care Act (S. 1461, H.R. 2803)
Prescription Drug Pricing Reduction Act of 2019
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Issues related to reporting of average sales prices to Medicare, including relevant provisions in the Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Reproductive Health legislation including Access to Infertility Treatment and Care Act (S. 1461, H.R. 2803)
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
S. 2960, H. 5965, "Access to Infertility Treatment Act." Legislation to require that health plans offered on the group and individual markets, in addition to the FEHB Program, TRICARE, and the VA provide coverage for in vitro fertility (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. H.R. 2097, "The Drug Pricing Transparency Act." Pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
S. 2960, H. 5965, "Access to Infertility Treatment Act." Legislation to require that health plans offered on the group and individual markets, in addition to the FEHB Program, TRICARE, and the VA provide coverage for in vitro fertility (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. H.R. 2097, "The Drug Pricing Transparency Act." Pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
S. 2960, H. 5965 - "Access to Infertility Treatment Act." Legislation to require that health plans offered on the group and individual markets, in addition to the FEHB Program, TRICARE and the VA provide coverage for in vitro fertility (IVF)treatments and fertility preservation (FP) for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. House and Senate legislation related to permanently allowing the Department of Veterans Affairs to offer reproductive services to veterans, including in vitro fertilization (IVF) treatments and repeal VA-ban of such services.
Drug Price Transparency Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
S. 2960 - "Access to Infertility Treatment Act." Legislation to require that health plans offered on the group and individual markets, in addition to the Federal Employees Health Benefits Program, TRICARE, and the VA provide coverage for in vitro fertilization (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. FY 2019 Senate Military Construction-VA Appropriations Bill - extending the Dept of Veterans Affairs' authorization allowing the agency to cover fertility services such as in vitro fertilization (IVF) for military service-connected injuries. H.R. 2087 - the "Drug Pricing Transparency Act:" pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Drug Price Transparency Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
S. 2960, H. 5965 - "Access to Infertility Treatment Care Act:" legislation to require that health plans offered on the group and individual markets, in addition to the Federal Employees Health Benefits Program, TRICARE and the VA provide coverage for in vitro fertility (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. FY 2019 Senate Military Construction-VA Appropriations Bill - extending the Dept of Veterans Affairs' authorization allowing the agency to cover fertility services such as in vitro fertility (IVF) for military service-connected injuries. H.R. 2087 - the Drug Pricing Transparency Act:" pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Drug Price Transparency Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
S. 2960, H. 5965 - "Access to Infertility Treatment Care Act:" legislation to require that health plans offered on the group and individual markets, in addition to the Federal Employees Health Benefits Program, TRICARE and the VA provide coverage for in vitro fertility (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. FY 2019 Senate Military Construction-VA Appropriations Bill - extending the Dept of Veterans Affairs' authorization allowing the agency to cover fertility services such as in vitro fertility (IVF) for military service-connected injuries. H.R. 2087 - the Drug Pricing Transparency Act:" pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Legacies of War Recognition and Unexploded Ordnance Removal Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
S. 2960, H. 5965, "Access to Infertility Treatment Act." Legislation to require that health plans offered on the group and individual markets, in addition to the FEHB Program, TRICARE, and the VA provide coverage for in vitro fertility (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. H.R. 2097, "The Drug Pricing Transparency Act." Pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Women Veterans and Families Health Services Act of 2019
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Federal legislation to guarantee insurance coverage of fertility treatments (no bill introduced) HR 955 / S 319, the Women Veterans and Families Health Services Act of 2019
Women Veterans and Families Health Services Act of 2019
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
Federal legislation to guarantee insurance coverage of fertility treatments (no bill introduced) HR 955 / S 319, the Women Veterans and Families Health Services Act of 2019
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
S. 2960, H. 5965, "Access to Infertility Treatment Act." Legislation to require that health plans offered on the group and individual markets, in addition to the FEHB Program, TRICARE, and the VA provide coverage for in vitro fertility (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. H.R. 2097, "The Drug Pricing Transparency Act." Pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
S. 2960, H. 5965 - "Access to Infertility Treatment Care Act:" legislation to require that health plans offered on the group and individual markets, in addition to the Federal Employees Health Benefits Program, TRICARE and the VA provide coverage for in vitro fertility (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. FY 2019 Senate Military Construction-VA Appropriations Bill - extending the Dept of Veterans Affairs' authorization allowing the agency to cover fertility services such as in vitro fertility (IVF) for military service-connected injuries. H.R. 2087 - the Drug Pricing Transparency Act:" pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
S. 2960, H. 5965 - "Access to Infertility Treatment Care Act:" legislation to require that health plans offered on the group and individual markets, in addition to the Federal Employees Health Benefits Program, TRICARE and the VA provide coverage for in vitro fertility (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. FY 2019 Senate Military Construction-VA Appropriations Bill - extending the Dept of Veterans Affairs' authorization allowing the agency to cover fertility services such as in vitro fertility (IVF) for military service-connected injuries. H.R. 2087 - the Drug Pricing Transparency Act:" pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
S. 2960 - "Access to Infertility Treatment Act." Legislation to require that health plans offered on the group and individual markets, in addition to the Federal Employees Health Benefits Program, TRICARE, and the VA provide coverage for in vitro fertilization (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. FY 2019 Senate Military Construction-VA Appropriations Bill - extending the Dept of Veterans Affairs' authorization allowing the agency to cover fertility services such as in vitro fertilization (IVF) for military service-connected injuries. H.R. 2087 - the "Drug Pricing Transparency Act:" pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Preventing Maternal Deaths Act of 2018
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 1318 and S. 1112, End Maternal Deaths Act - enacted into law, Dec. 21, 2018 H. 5965 and S. 2960, Fair Access to Fertility Treatment Act Proposal to include funding for fertility benefits for Dept. of Veterans Affairs through Senate VA MilCon Appropriations Bill
Preventing Maternal Deaths Act of 2018
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
HR 1318, S 1112; issues relating to maternal mortality legislation HR 5965, S2960, Access to Fertility Treatment and Care Act
Preventing Maternal Deaths Act of 2018
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R 1318 Preventing Maternal Deaths Act of 2017 S. 1112 Maternal Health Accountability Act of 2017 H.R. 5965, S. 2960 The Access to Infertility Treatment and Care Act
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
HR 1318, S 1112; issues relating to maternal mortality legislation HR 5965, S2960, Access to Fertility Treatment and Care Act
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R 1318 Preventing Maternal Deaths Act of 2017 S. 1112 Maternal Health Accountability Act of 2017 H.R. 5965, S. 2960 The Access to Infertility Treatment and Care Act
Maternal Health Accountability Act of 2017
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R 1318 Preventing Maternal Deaths Act of 2017 S. 1112 Maternal Health Accountability Act of 2017 H.R. 5965, S. 2960 The Access to Infertility Treatment and Care Act
Maternal Health Accountability Act of 2017
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 1318 and S. 1112, End Maternal Deaths Act - enacted into law, Dec. 21, 2018 H. 5965 and S. 2960, Fair Access to Fertility Treatment Act Proposal to include funding for fertility benefits for Dept. of Veterans Affairs through Senate VA MilCon Appropriations Bill
Maternal Health Accountability Act of 2017
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
HR 1318, S 1112; issues relating to maternal mortality legislation HR 5965, S2960, Access to Fertility Treatment and Care Act
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R 1318 Preventing Maternal Deaths Act of 2017 S. 1112 Maternal Health Accountability Act of 2017 H.R. 5965, S. 2960 The Access to Infertility Treatment and Care Act
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
H.R. 1318 and S. 1112, End Maternal Deaths Act - enacted into law, Dec. 21, 2018 H. 5965 and S. 2960, Fair Access to Fertility Treatment Act Proposal to include funding for fertility benefits for Dept. of Veterans Affairs through Senate VA MilCon Appropriations Bill
Access to Infertility Treatment and Care Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: FERRING PHARMACEUTICALS, INC.
HR 1318, S 1112; issues relating to maternal mortality legislation HR 5965, S2960, Access to Fertility Treatment and Care Act
2022 · second_quarter · Q2
Issues related to advancing H.R. 4450 and S.2352, the Access to Infertility Treatment and Care Act Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem.... S.Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) H.R. 1957, Veterans Infertility Treatment Act Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare H.Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA), White House Office
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2022 · first_quarter · Q1
Issues related to advancing H.R. 4450 and S.2352, the Access to Infertility Treatment and Care Act Issues related to advancing H.Res. 338, A Resolution Recognizing that Infertility is a widespread problem.... S.Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) H.R. 1957, Veterans Infertility Treatment Act Issues related to mandating Infertility treatment and care for military personnel and military veterans under TriCare H.Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA), White House Office
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2021 · fourth_quarter · Q4
H.R. 4450 / S. 2352 - Access to Infertility Treatment and Care Act (Entire bill); H. Res. 338 - Recognizing that infertility is a widespread problem that affects populations of diverse ages, races, ethnicities, and genders (Entire resolution); H.R. 1957 - Veterans Infertility Treatment Act of 2021 (Entire bill); H.R. 2734 / S.1280 - Veteran Families Health Services Act of 2021 (Entire bill); H.R. 6094 - Expanding Access to Fertility Care for Servicemembers and Dependents Act (Entire bill); H.R. 7900 - National Defense Authorization Act (NDAA) for Fiscal Year 2023 (Issues related to fertility coverage for members of the military); H.R. 8237 - Legislative Branch Appropriations Act, 2023 (Issues related to fertility coverage); H.R. 8238 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023 (Issues related to fertility coverage for members of the military); H.R. 4432 - Department of Defense Appropriations Act, 2022 (Issues related to fertility coverage for members of the military); S. Res. 325, A Resolution recognizing the seriousness of polycystic ovary syndrome (Entire bill); H. Res. 539, A Resolution recognizing the maternal health crisis in the United States, and issues related to addressing the maternal health crisis in the United States (Entire resolution)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2021 · third_quarter · Q3
H.R. 1957 - Veterans Infertility Treatment Act and issues related to mandating health coverage for military veterans
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill) H.R. 1957 - Veterans Infertility Treatment Act of 2021
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2021 · first_quarter · 1A
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA), White House Office
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2021 · second_quarter · Q2
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2021 · first_quarter · Q1
Issues related to reporting of average sales price to Medicare, including relevant provisions in Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Issues related to advancing Access to Infertility Treatment and Care Act (H.R. 2803, S. 1461) Issues related to advancing Access to Infertility Treatment for Military Veterans (no bill)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2020 · fourth_quarter · Q4
Issues related to reporting of average sales prices to Medicare, including relevant provisions in the Lower Drug Costs Now Act (H.R. 3), Prescription Drug Pricing Reduction Act (S. 2543), Prescription Drug STAR Act (H.R. 2113), Strengthening Average Sales Price Reporting Act (S. 2051), and Consolidated Appropriations Act, 2021 (H.R. 133) Reproductive Health legislation including Access to Infertility Treatment and Care Act (S. 1461, H.R. 2803)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2020 · third_quarter · Q3
S. 2960, H. 5965 - "Access to Infertility Treatment Act." Legislation to require that health plans offered on the group and individual markets, in addition to the FEHB Program, TRICARE and the VA provide coverage for in vitro fertility (IVF)treatments and fertility preservation (FP) for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. House and Senate legislation related to permanently allowing the Department of Veterans Affairs to offer reproductive services to veterans, including in vitro fertilization (IVF) treatments and repeal VA-ban of such services.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2020 · second_quarter · Q2
S. 2960, H. 5965, "Access to Infertility Treatment Act." Legislation to require that health plans offered on the group and individual markets, in addition to the FEHB Program, TRICARE, and the VA provide coverage for in vitro fertility (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. H.R. 2097, "The Drug Pricing Transparency Act." Pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2020 · first_quarter · Q1
S. 2960, H. 5965, "Access to Infertility Treatment Act." Legislation to require that health plans offered on the group and individual markets, in addition to the FEHB Program, TRICARE, and the VA provide coverage for in vitro fertility (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. H.R. 2097, "The Drug Pricing Transparency Act." Pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2019 · fourth_quarter · Q4
S. 2960, H. 5965, "Access to Infertility Treatment Act." Legislation to require that health plans offered on the group and individual markets, in addition to the FEHB Program, TRICARE, and the VA provide coverage for in vitro fertility (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. H.R. 2097, "The Drug Pricing Transparency Act." Pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2019 · third_quarter · Q3
S. 2960 - "Access to Infertility Treatment Act." Legislation to require that health plans offered on the group and individual markets, in addition to the Federal Employees Health Benefits Program, TRICARE, and the VA provide coverage for in vitro fertilization (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. FY 2019 Senate Military Construction-VA Appropriations Bill - extending the Dept of Veterans Affairs' authorization allowing the agency to cover fertility services such as in vitro fertilization (IVF) for military service-connected injuries. H.R. 2087 - the "Drug Pricing Transparency Act:" pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2019 · second_quarter · 2A
S. 2960, H. 5965 - "Access to Infertility Treatment Care Act:" legislation to require that health plans offered on the group and individual markets, in addition to the Federal Employees Health Benefits Program, TRICARE and the VA provide coverage for in vitro fertility (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. FY 2019 Senate Military Construction-VA Appropriations Bill - extending the Dept of Veterans Affairs' authorization allowing the agency to cover fertility services such as in vitro fertility (IVF) for military service-connected injuries. H.R. 2087 - the Drug Pricing Transparency Act:" pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2019 · second_quarter · Q2
S. 2960, H. 5965 - "Access to Infertility Treatment Care Act:" legislation to require that health plans offered on the group and individual markets, in addition to the Federal Employees Health Benefits Program, TRICARE and the VA provide coverage for in vitro fertility (IVF) treatments and fertility preservation treatments for patients who undergo medically necessary procedures that may cause infertility, such as chemotherapy. FY 2019 Senate Military Construction-VA Appropriations Bill - extending the Dept of Veterans Affairs' authorization allowing the agency to cover fertility services such as in vitro fertility (IVF) for military service-connected injuries. H.R. 2087 - the Drug Pricing Transparency Act:" pertaining to manufacturer reporting to CMS of the average sales price (ASP) of products reimbursed by Medicare Part B drugs, specifically including products approved by the FDA as medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2019 · first_quarter · Q1
Federal legislation to guarantee insurance coverage of fertility treatments (no bill introduced) HR 955 / S 319, the Women Veterans and Families Health Services Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2018 · fourth_quarter · Q4
H.R. 1318 and S. 1112, End Maternal Deaths Act - enacted into law, Dec. 21, 2018 H. 5965 and S. 2960, Fair Access to Fertility Treatment Act Proposal to include funding for fertility benefits for Dept. of Veterans Affairs through Senate VA MilCon Appropriations Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2018 · third_quarter · 3A
HR 1318, S 1112; issues relating to maternal mortality legislation HR 5965, S2960, Access to Fertility Treatment and Care Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2018 · second_quarter · 2A
H.R 1318 Preventing Maternal Deaths Act of 2017 S. 1112 Maternal Health Accountability Act of 2017 H.R. 5965, S. 2960 The Access to Infertility Treatment and Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2018 · first_quarter · Q1
House and Senate Military Construction and Veterans Affairs and related Agencies Appropriations Act. Legislation to lift ban on offering in vitro fertilization (IVF) by the Veterans Administration to certain disabled veterans. Legislation to allow pilot program to provide cryopreservation by Department of Defense. Legislation to prevent maternal deaths and to identify solutions to improve health care quality and health outcomes for mother (Bill 1112 U.S. Senate/Bill 1318 House of Representatives)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2017 · fourth_quarter · Q4
House and Senate Military Construction and Veterans Affairs and related Agencies Appropriations Act. Legislation to lift ban on offering in vitro fertilization (IVF) by the Veterans Administration to certain disabled veterans. Legislation to allow pilot program to provide cryopreservation by Department of Defense. Legislation to prevent maternal deaths and to identify solutions to improve health care quality and health outcomes for mother.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2017 · first_quarter · 1A
House and Senate Military Construction and Veterans Affairs and related Agencies Appropriations Act. Legislation to lift ban on offering in vitro fertilization (IVF) by the Veterans Administration to certain disabled veterans. Legislation to allow pilot program to provide cryopreservation by Department of Defense.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2017 · third_quarter · Q3
House and Senate Military Construction and Veterans Affairs and related Agencies Appropriations Act. Legislation to lift ban on offering in vitro fertilization (IVF) by the Veterans Administration to certain disabled veterans. Legislation to allow pilot program to provide cryopreservation by Department of Defense. Legislation to prevent maternal deaths and to identify solutions to improve health care quality and health outcomes for mother.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2017 · second_quarter · 2A
House and Senate Military Construction and Veterans Affairs and related Agencies Appropriations Act. Legislation to lift ban on offering in vitro fertilization (IVF) by the Veterans Administration to certain disabled veterans. Legislation to allow pilot program to provide cryopreservation by Department of Defense.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2017 · third_quarter · RA
House and Senate Military Construction and Veterans Affairs and related Agencies Appropriations Act. Legislation to lift ban on offering in vitro fertilization (IVF) by the Veterans Administration to certain disabled veterans. Legislation to allow pilot program to provide crysopreservation by Department of Defense.
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2016 · third_quarter · Q3
House and Senate Military Construction and Veterans Affairs and Related Agencies Appropriations Act Legislation to lift ban on offering in vitro fertilization (IVF) by the Veterans Administration to certain disabled veterans Legislation to allow pilot program to provide cryopreservation by Department of Defense
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS, INC. via FERRING PHARMACEUTICALS, INC.
2016 · second_quarter · Q2
House and Senate Military Construction and Veterans Affairs and Related Agencies Appropriations Act Legislation to lift ban on offering in vitro fertilization (IVF) by the Veterans Administration to certain disabled veterans Legislation to allow pilot program to provide cryopreservation by Department of Defense
Filing targets: HOUSE OF REPRESENTATIVES, SENATE